The spalt proteins are encoded by a family of evolutionarily conserved genes found in species as diverse as Drosophila, C. elegans and vertebrates. In humans, mutations in some of these genes are associated with several congenital disorders which underscores the importance of spalt gene function in embryonic development. Recent studies have begun to cast light on the functions of this family of proteins with increasing understanding of the developmental processes regulated and the molecular mechanisms used. Here we review what is currently known about the role of spalt genes in vertebrate development and human disease.
Introduction
The spalt genes were originally identified in Drosophila, which has two members of the family, spalt major (salm) and spalt related (salr). These have important roles in processes as diverse as homeotic specification of the embryonic termini (Jürgens, 1988; Kuhnlein et al., 1994) , wing patterning (de Celis and Barrio, 2000) , sensory organ development , tracheal system development and specification of photoreceptors (Domingos et al., 2004a,b) . Vertebrate homologues of spalt have been shown to be involved in normal development and are implicated in several human genetic disorders. Here we will review the developmental roles of this gene family with reference to both animal model organisms and human disease. The spalt genes are known to be mutated in several human congenital syndromes and studies of the mutations associated with these syndromes have been critical in our current understanding of spalt gene function. Finally, we will discuss how the developmental and disease studies relate to what is currently known about the structure/function of these proteins. We will also discuss the relationships between these genes and propose a unified nomenclature system for future use (see box, Fig. 1 and Table 1 ).
Spalt proteins in development
Recent work has demonstrated that spalt genes are required for the normal development of the limbs and nervous system and several organs including the kidney and heart. In this section, we discuss which members of this gene family are necessary in these systems, the mechanisms by which they are thought to act and highlight some of the as yet unanswered questions about these genes in development.
Limb development
The association of several syndromes affecting normal limb development with mutations in the SALL genes suggests a critical role of these proteins in the limb. Several members of the spalt family are known to be expressed during limb development including Sall1, Sall3 and Sall4 in mouse (Buck et al., 2001; Kohlhase et al., 2002a; Ott et al., 1996 Ott et al., , 2001 , csall1, csall3 and csall4 in chick (Barembaum and Bronner-Fraser, 2004; Farrell and Münsterberg, 2000; Farrell et al., 2001 ) and Xsall3 and Xsall4a in Xenopus (Hollemann et al., 1996; Neff Developmental Biology 293 (2006) 285 -293 www.elsevier.com/locate/ydbio et al., 2005) . These genes are expressed in overlapping patterns and may well affect limb patterning and development in a cocoordinated way. Very little is known about the regulation of spalt genes in the developing limb; however, it has been shown that endogenous csall1 expression in the distal part of the limb bud requires FGF and Wnt signaling (Farrell and Münsterberg, 2000) . In the proximal limb, csall1 expression can be induced ectopically by BMP-2 although this may reflect an induction of distal limb fate in this case rather than endogenous regulation (Capdevila et al., 1999) . The range of possible interactions between different spalt proteins will vary across the limb bud depending on the precise combination of spalt proteins present and it is tempting to speculate that this could modulate function and produce different activities in different areas. For example in part of the chick limb bud, csall1 is coexpressed with csall3. It is known that the chick protein csall3 is cytoplasmic and can remove full-length spalt protein from the nucleus, providing another possible level of regulation of protein activity (Sweetman et al., 2003) . In the mouse limb, no defects are observed in loss of function Sall1 mutations but patterning is disrupted in the presence of truncated Sall1 protein (McLeskey Kiefer et al., 2003; Nishinakamura et al., 2001) . These findings are discussed further in the section on SALL1 in Townes-Brocks syndrome (TBS) below. In Xenopus, Xsall4a is expressed both during normal limb development and regeneration (Neff et al., 2005) . Recent evidence has also shown that in zebrafish sall1 and sall4 are regulated by tbx5 in pectoral fin development and are required for regulation of FGF signaling (Harvey and Logan, 2006) . The control of these genes by tbx5 may explain the clinical overlap between Holt-Oram syndrome and Okihiro syndrome with mutations in TBX5 and SALL4 giving remarkably similar phenotypes (see SALL4 in developmental disorders). The details of how spalt proteins affect limb patterning are unclear but one possibility is that they interact genetically with members of the Iroquois gene family. These genes are expressed during vertebrate limb development (Houweling et al., 2001; Zulch et al., 2001 ) and in Drosophila it is known that interactions between the spalt and iroquois gene families are required in wing patterning (de Celis and Barrio, 2000) .
Nomenclature
Vertebrate spalt proteins fall into four groups, with four genes in human called SALL1-4 (Kohlhase et al., 1996 (Kohlhase et al., , 1999 (Kohlhase et al., , 2002b . Four genes have been identified in mouse, Sall1-4 (Buck et al., 2001; Kohlhase et al., 2000 Kohlhase et al., , 2002a Ott et al., 1996 Ott et al., , 2001 , three in chick (Barembaum and Bronner-Fraser, 2004; Farrell and Münsterberg, 2000; Farrell et al., 2001) , five in Xenopus (Hollemann et al., 1996; Neff et al., 2005; Onai et al., 2004; Onuma et al., 1999) , three in zebrafish (Camp et al., 2003) and one in Medaka (Koster et al., 1997) . A phylogenetic tree indicating the relationship of these homologues is shown in Fig. 1 . The nomenclature for these genes is not entirely consistent and for the purposes of clarity in this review we will refer to all vertebrate spalt genes as spalt like (abbreviated sall). Table 1 shows our proposed nomenclature based on this phylogeny. Human and mouse genes retain their current names while those of other species have been changed to correspond to these genes. As Fig. 1 shows, the spalt genes fall into four distinct groups with the SALL1 and SALL3 groups being most closely related. This phylogeny suggests that an ancestral spalt diverged to produce the SALL2 group with further duplications producing the SALL4 group and then the SALL1 and SALL3 groups. The status of the zebrafish sall1b is least clear. Comparison of protein sequences shows that it has 55.2% identity with zebrafish sall1 and 52.4% identity with zebrafish sall3 and it is possible that this gene is of a subfamily unique to zebrafish. Fig. 1 . Clustal alignment of vertebrate spalt protein sequences. Four orthologous groups can be identified based on sequence similarity, which are termed SALL1, SALL2, SALL3 and SALL4 groups based on the human gene.
Heart development
In the developing heart, expression has been reported of Sall1 in mouse (Buck et al., 2001; Ott et al., 2001) , sall1 in zebrafish (Camp et al., 2003) and csall1 in chick (Sweetman et al., 2005) . Together with the presence of heart defects in TBS (Kohlhase et al., 2003a ) (see SALL1 in Townes-Brocks syndrome), this is strongly suggestive of a role in heart development. Interestingly in the developing chick embryo, csall1 expression is observed not only in the sinus venosus of the heart itself but also in the pharynx at the same axial level (Sweetman et al., 2005) . The pharynx is known to be involved in the inductive events required for cardiac neural crest specification and disruptions to this population of cells can result in ventral septal defect and Tetralogy of Fallot (Creazzo et al., 1998; Farrell et al., 1999) . These defects are also occasionally seen in TBS. This would be consistent with an additional indirect role of csall1 in heart development via the regulation of inductive events mediated by the pharynx.
Neural development
Many spalt genes are expressed in the developing nervous system; however, only recently have studies begun to cast light on the function of these genes in neural development. In Xenopus, Xsall2 has been shown to be required for the determination of the forebrain/midbrain and for repressing the acquisition of a more caudal midbrain/hindbrain fate. It is interesting to note that in this context Xsall2 acts by repressing canonical Wnt signaling which acts to posteriorize the neural tissue in the absence of Xsall2 (Onai et al., 2004) . This is in contrast to the reported ability of Sall1 to enhance canonical Wnt signaling (Sato et al., 2004) and it remains to be determined whether this difference is due to cellular context or to different properties of these spalt proteins. Another report shows that in the chick embryo csall4 expression is required for the correct migration of neural crest cells into the sensory ganglia. Neural crest cells overexpressing csall4 do not migrate normally into the ganglia and do not express differentiation markers. The authors suggest that csall4 is required for these cells to remain undifferentiated and that this could affect the ability of these cells to form neurons (Barembaum and Bronner-Fraser, 2004) . Cranial nerve development is also disrupted in a Sall3 null mouse model. In these mice, the nerves that innervate the oral cavity do not form normally, particularly the glossopharyngeal nerve (Parrish et al., 2004) . Together, these studies demonstrate important and varied roles for the spalt genes in the normal development of the nervous system.
Kidney development
Mice homozygous for a null mutation in Sall1 die perinatally due to renal agenesis. In these animals, the uteric bud does not grow out, tubules do not form and the metanephric mesenchyme undergoes apoptosis. Although these defects occur in the nephrogenic mesenchyme, the mesenchyme itself can be rescued by wild type tissue. Therefore, it is the inductive signals leading to uteric bud invasion that fail under these conditions (Nishinakamura et al., 2001) . In another mouse model where a truncated Sall1 protein is expressed, homozygous mice have renal agenesis, while in heterozygous mice with one wild type Sall1 allele renal cystic hypoplasia results (McLeskey Kiefer et al., 2003) . Another link between SALL1 and kidney development comes from studies of patients with Townes-Brocks syndrome which is associated with kidney defects (Powell and Michaelis, 1999) . In other species, spalt genes are also expressed in the developing kidney with sall1a in zebrafish and Xsall4b in Xenopus expressed in the pronephric ducts (Camp et al., 2003; Onuma et al., 1999) while in the chick embryo csall3 is expressed in the mesonephros (Farrell et al., 2001) . The range of different spalt genes expressed in kidney development in different species suggests some divergence in function with other spalt genes substituting for SALL1 in both Xenopus and chick embryos.
Future directions
The regulation of spalt gene expression has not yet been examined in detail in most of the organ systems known to require these genes. The regulation of Drosophila spalt has been studied and shown to respond to a gradient of the TGFβ homologue dpp Smith, 1996) and the T box gene omb (del Alamo Rodriguez et al., 2004) ; in vertebrates the only known regulators are Shh in the Medaka midbrain/ hindbrain boundary (Koster et al., 1997) and FGF and Wnt signaling in the distal limb bud (Farrell and Münsterberg, 2000) although BMP signaling can induce ectopic csall1 expression in the proximal limb (Capdevila et al., 1999) . Further elucidation of the spatio-temporal regulation will be critical in the understanding of how these proteins are able to affect the Barrio, 2000) and is itself controlled by the T box gene optomotor blind (del Alamo Rodriguez et al., 2004) . In vertebrate limb development, homologues of these genes are known to be required for normal patterning and mutations in one vertebrate T box gene, TBX5, also lead to Holt-Oram syndrome, as can mutations in SALL4. The discovery that tbx5 regulates sall1 and sall4 in zebrafish pectoral fin development (Harvey and Logan, 2006) and that Tbx5 and Sall4 interact in mouse heart and limb development (Koshiba-Takeuchi et al., 2006) underscores the conservation of spalt gene function across species. In the future, it will be fascinating to determine if other functional relationships known from Drosophila are also conserved in vertebrates, such as the interaction between spalt and Iroquis gene families, and what implications this has for normal limb development.
Another area that is currently not well understood is the role of spalt genes in ear development. This is of particular interest as mutations in some human spalt genes lead to outer ear and auditory defects. Unpublished data from chick embryos indicate that csall4 is required for the invagination of sensory placodes (M. Bronner Fraser, personal communication) and this will be an exciting area for further investigation.
Spalt genes in human disease
One of the striking aspects of spalt biology is the clear association of mutations within this gene family with congenital syndromes affecting limb, ear, kidney and heart development. Much of the work on developmental aspects of spalt gene function has been based on information from studies of these patients. In this section, we describe the relationships between these syndromes and mutations in the human spalt genes and how these have provided valuable insights into the function of these proteins in normal development.
SALL1 in Townes-Brocks syndrome
Townes-Brocks syndrome (TBS) is an autosomal dominant disorder characterized by preaxial polydactyly and triphalangeal thumbs, external ear defects and sensorineural hearing loss, imperforate anus, kidney defects and heart defects including Tetralogy of Fallot and ventricular septal defects (Powell and Michaelis, 1999) with some rare cases of patients also showing a variety of other phenotypic anomalies (Botzenhart et al., 2005) . Mutations in SALL1 have been shown to result in TBS (Kohlhase et al., 1998) . Most of these mutations cause premature stop codons in the 5′ region of the gene which, if transcribed, would lead to the production of truncated forms of the SALL1 protein that terminate after the glutamine rich region and around the region of the first set of C2H2 zinc fingers leading to a predicted protein containing either none or only one of the C2H2 domains (Botzenhart et al., 2005; Kohlhase, 2000) (see Fig. 2 ). The question of whether or not these mutations actually lead to the expression of truncated SALL1 proteins has not been resolved and initial reports suggested that TBS is caused by haploinsuffiency at the SALL1 locus caused by nonsense-mediated decay of the mutant transcript (Kohlhase et al., 1998) . This hypothesis did not explain the clustering of mutations and several studies have suggested an alternative possibility, namely that truncated proteins produced from the SALL1 locus can act in a dominant negative manner, interfering with the function of full-length SALL1 protein. Intriguingly transfection experiments have shown that truncated proteins similar to those potentially present in TBS patients are expressed throughout the cell. They can interact with fulllength spalt proteins and can cause full-length protein to be relocalized from the nucleus to the cytoplasm providing a potential mechanism of dominant negative interference (McLeskey Kiefer et al., 2003; Sweetman et al., 2003) . Studies in transgenic mice also support the idea of dominant negative activity by truncated spalt protein. Mice completely lacking Sall1 show renal agenesis but lack the features associated with TBS (Nishinakamura et al., 2001 ). If haploinsufficiency is indeed the underlying cause of TBS in human, then mice carrying null alleles of Sall1 might be expected to show a phenotype similar to that seen in TBS even though transgenic and knock out mice do not always completely recapitulate human disease phenotypes; however, heterozygous Sall1 null mice have no apparent defects. In contrast, mice carrying a knock-in into the Sall1 locus of a cDNA encoding a protein with a truncation similar to that predicted to be present in TBS have a range of defects much more reminiscent of TBS including sensorineural hearing loss, renal cystic hypoplasia and limb abnormalities (McLeskey Kiefer et al., 2003) . That truncating mutations of SALL1 orthologues can affect the function of fulllength protein has been well established in vitro; however, so far truncated proteins have not been detected in TBS patients. Recently, further evidence has shown that some TBS patients carry deletions which entirely remove one SALL1 allele and in these cases haploinsufficiency can safely be assumed to lead to TBS; however, it is interesting to note that these cases show a milder phenotype than those associated with truncating mutations in SALL1 (Borozdin et al., 2006) . One plausible interpretation of these data is that while loss of one SALL1 allele can cause TBS, a truncated protein has a stronger effect and produces a more severe phenotype. The potential dominant negative activity of truncated spalt proteins also raises the possibility that truncated SALL1 protein could interact with and affect the function of other spalt proteins as these truncations are able to interact with all full-length spalt genes so far tested (McLeskey Kiefer et al., 2003; Sweetman et al., 2003) . For example in limb development at least three spalt proteins (1, 3 and 4) are known to be expressed in partially overlapping domains and the presence of a truncated SALL1 protein could therefore potentially affect the functioning of all of them. Thus, it may be the case that TBS is caused by interfering with the function of multiple SALL proteins during embryonic development. Interestingly, in Drosophila, flies carrying mutations in both spalt and spalt related show defects in antennal, genital and auditory defects, remarkable evidence of functional conservation of spalt gene function across vertebrate and invertebrate development (Dong et al., 2003) .
While TBS is the best understood of the diseases caused by spalt gene defects, there remain some unanswered questions. In Townes-Brocks syndrome, the truncating mutations in SALL1 are potentially able to interfere with the activity of any other spalt gene coexpressed in the same cell. Based on mouse models, it appears that the kidney defects observed may well be due to reduced function of SALL1 protein while the patterning defects in the ear and limb are likely to be caused by dominant negative effects on other members of the family expressed in these tissues as well as SALL1 (McLeskey Kiefer et al., 2003; Nishinakamura et al., 2001) . The requirement for csall4 in the invagination of sensory placodes (M. Bronner Fraser, personal communication) is consistent with the idea that the ear defects seen in TBS may result from interference with SALL4 as well as SALL1.
SALL4 in developmental disorders
Mutations in SALL4 have been found in a range of clinically overlapping syndromes including Okihiro syndrome (also known as acro-renal-ocular syndrome or Duane radial ray syndrome), Holt-Oram syndrome and some cases previously thought to be thalidomide embryopathy (Borozdin et al., 2004a,b; Kohlhase et al., 2002b Kohlhase et al., , 2003b . These syndromes present with defects in limb and heart development with Okihiro syndrome also showing defects in eye and kidney development. Although there is phenotypic variability in patients identified to have SALL4 mutations, there is no clear correlation between specific mutations and phenotypes . Unlike SALL1 mutations in TBS, the mutations observed in these cases do not cluster around a critical region and haploinsuffiency has been shown to be the cause of these disorders (Borozdin et al., 2004a) . The clinical overlap between these syndromes and TBS reinforces the idea that a dominant negative effect of a SALL1 truncation on SALL4 function may be involved in TBS.
Spalt proteins in cancer
A possible role for SALL1 in Wilms tumor was reported when high levels of expression were observed in these cancers (Ma et al., 2001b) . Another spalt gene, SALL2, was shown to be repressed by the Wilms tumor protein, WT1 (Ma et al., 2001a) . SALL2 is perhaps the most likely candidate for a tumor suppressor gene as its mouse orthologue binds to the oncogenic polyoma large T antigen and has been shown to upregulate p21 expression (Li et al., 2001 (Li et al., , 2004 . SALL1 may also have a role in tumorigenesis via its ability to enhance Wnt signaling (Sato et al., 2004) . To date, there has been no firm evidence to support the idea that spalt proteins can act as tumor suppressors. However, if this were the case, one would predict that syndromes with either null or dominant negative mutations would correlate with an increased risk of cancer but this has not been reported and therefore the case for spalt genes in cancer aetiology remains speculative.
SALL3 in 18q deletion syndrome
Very little is known about the role of spalt genes in 18q deletion syndrome which comprises a wide range of developmental defects including mental retardation, hearing loss and digit abnormalities. Although SALL3 is likely to be lost in these deletions, it is one of several genes within this region and so cannot be regarded as the sole cause of this syndrome. Nevertheless, it remains possible that hemizygosity of SALL3 is responsible for at least some of the features observed in this syndrome (Kohlhase et al., 1999) .
Structure and function of the spalt proteins
Developmental, clinical and biochemical studies have all contributed to our understanding of how the structure of the spalt proteins relates to their function. The combination of these approaches has provided critical insights into how this gene family operates during development and how mutation can lead to clinical disorders. In this section, we discuss what is known about the structure-function relationship of the spalt proteins and how this knowledge relates to the developmental and disease aspects of spalt gene activity.
Structure
The spalt proteins range from 105 to 140 kDa and have several conserved features including an N-terminal zinc finger domain of the C2HC type (which is not present in Drosophila spalt proteins), a glutamine-rich region and several double or triple zinc fingers of the C2H2 type throughout the protein with the precise number and spacing of these varying across the family. The predicted structures of the four human spalt proteins are shown in Fig. 2 . In SALL1 group proteins characterized to date, there are 9 of these C2H2 zinc fingers. However, in the other groups, there seems to be variability with respect to zinc fingers 6 and 7. For example, in the predicted protein structures of SALL2 and SALL4, zinc fingers 6 and 7 are absent, while Xsall2, although closest to SALL2 in terms of its protein sequence, contains additional zinc fingers (Onai et al., 2004) . It is also notable that the C terminal zinc fingers in SALL2 are not homologous to those seen in other spalt proteins lacking, for example, the distinctive 'SAL box' seen in other zinc fingers in these proteins. This suggests that these zinc fingers in SALL2 may have a separate origin to those in other spalt proteins. In the chick, csall3 is missing zinc fingers 6 and 7 compared to SALL3 (Farrell et al., 2001 ). However, the genomic sequence of csall3 contains a predicted exon containing these missing zinc fingers and RT-PCR experiments suggest that an alternative splice variant of csall3, containing these additional zinc fingers, is expressed during development (DS and AM, unpublished data). As yet, little is known about the prevalence and extent of alternative splice forms of the spalt proteins and the possible functional consequences of this, and this may well prove to be an important area in the study of these genes.
Transcriptional regulation by spalt genes
Spalt proteins are thought to act as transcription factors although few target genes have been identified. Support for a role in transcriptional regulation has come from studies using fusion proteins of SALL1, Sall1, csall1 and csall3 to the GAL4 DNA binding domain. These fusion proteins are able to repress transcription from a GAL4 responsive promoter. Furthermore, in the case of Sall1, this ability was mapped to the N-terminal zinc finger which has been shown to interact with histone deactylase to mediate repression (McLeskey Kiefer et al., 2002; Netzer et al., 2001; Sweetman et al., 2003) . To date, the only demonstration of transcriptional regulation by a vertebrate spalt on a native promoter has come from studies of SALL2 which has been shown to bind to and regulate the activity of the CDK inhibitor p21 promoter (Li et al., 2004) . Strikingly, SALL2 binding to the p21 promoter increases transcription and so provides evidence of positive regulation of transcription by this family of proteins. SALL1 has also been shown to act as a positive regulator of β-catenin-dependent Wnt signaling and this activity correlates with its ability to bind heterochromatin within the nucleus (Sato et al., 2004) . In this study, SALL1 was shown to interact with β-catenin in coimmunoprecipitation assays but did not completely colocalize with β-catenin within the nucleus. The precise role of the spalt proteins in transcriptional regulation remains to be elucidated although evidence so far suggests that interactions with other proteins are likely to be critical in this process (see below). More spalt responsive promoters will have to be examined in order to obtain a more complete understanding of the mechanisms by which spalt proteins affect target gene expression.
Interactions of spalt proteins
The function of the spalt proteins is likely to be modulated through interactions with other proteins in multi protein complexes. The spalt proteins themselves can form both homo-and heteromeric complexes and to date all members of the family that have been tested show the ability to interact with each other in coimmunoprecipitation assays (McLeskey Kiefer et al., 2003; Sweetman et al., 2003) . These interactions are mediated by the N-terminal region of the protein and require the glutamine-rich region, and proteins lacking this domain do not coprecipitate. It has been demonstrated that spalt protein interactions can influence subcellular localization and thereby potentially modify function. For example, full-length SALL1, Sall1 and csall1 have all been shown to localize to the nucleus as expected for a transcriptional regulator (McLeskey Kiefer et al., 2002; Netzer et al., 2001; Sweetman et al., 2003) . However, csall3 is found in the cytoplasm and, when coexpressed with csall1, can cause the relocalization of csall1 from the nucleus to the cytoplasm (Sweetman et al., 2003) . The expression pattern of csall1 and csall3 during limb development is partially overlapping. This finding, together with the cellular localization studies, suggests a mechanism whereby the activity of csall1 in the nucleus can be modulated across the limb bud by coexpression of csall3, and this may be important for normal limb development.
Other proteins that have been shown to interact with spalt proteins include HDAC and β-catenin. In addition, SALL1 has been shown to interact with TRF1/PIN2 (Netzer et al., 2001 ), UBE2I and SUMO-1 (Netzer et al., 2002) and Sall2 with polyoma virus large T antigen (Li et al., 2001 ). It will be important to dissect the implications of these interactions for spalt protein function in both development and disease.
While it is known that spalt proteins can interact in vitro, it is not clear if this happens in vivo and, if so, what the consequences might be. It is possible that target gene expression may be modified by different combinations of spalt proteins and this could explain why discrete but overlapping expression patterns are seen in different regions of the embryo, for example the developing limb and kidney. There is good evidence for both repressive and activating functions on target gene expression, presumably dependent on cellular context. Although GAL4 fusions have uncovered transcriptional repressor activity and this has been linked to interaction with HDAC, the only known target gene in vertebrates so far, p21, is upregulated in the presence of SALL2 (Li et al., 2004) . Understanding the details of these of these processes, including the identification of further spalt targets, will be critical in our attempts to unravel the function of this family of proteins in development.
Future directions
One area of interest that requires further elucidation is the subcellular localization of the spalt proteins. SALL1 and its orthologues are nuclear, as would be expected of transcription factors, but at least one family member, csall3 in chick, has been shown to be cytoplasmic. The ability of csall3 to remove csall1 from the nucleus when both proteins are coexpressed suggests a role in negative regulation of other spalt proteins. However, this may not be the whole story. Preliminary data from our lab show that csall3 undergoes tyrosine phosphorylation while csall1 does not. Furthermore, upon withdrawal of serum, csall3 can enter the nucleus (DS and AM, unpublished). This implies a further level of control of spalt activity where phosphorylation, induced by growth factors, can alter subcellular localization and thus potentially transcriptional activity of at least one member of the spalt family. The possible existence of a splice variant of (Kohlhase et al., 1998) sall1, sall3, N terminal truncations of sall1 (McLeskey Kiefer et al., 2003; Sweetman et al., 2003) FGFs/Wnts (Farrell and Münsterberg, 2000) Limb patterning (McLeskey Kiefer et al., 2003) , kidney development (Nishinakamura et al., 2001 ) HDAC (McLeskey Kiefer et al., 2002) BMP (Capdevila et al., 1999) UBE21, SUMO-1 (Netzer et al., 2002) SALL2 N terminal truncations of sall1 (McLeskey Kiefer et al., 2003) Wilms tumor protein (Ma et al., 2001a) None known (Sato et al., 2003) p21 (Li et al., 2004 ) Polyoma virus large T (Li et al., 2001 ) SALL3 18q23 deletion syndrome (?) (Kohlhase et al., 1999) sall1 full-length and N terminal truncations (McLeskey Kiefer et al., 2003; Sweetman et al., 2003) Palate formation, cranial nerve development (Parrish et al., 2004) 
SALL4
Okiihiro syndrome (Kohlhase et al., 2002b) Holt-Oram and acro-renal-ocular syndrome (Kohlhase et al., 2003a,b) N terminal truncations of sall1 (McLeskey Kiefer et al., 2003) Tbx5 (Harvey and Logan, 2006; Koshiba-Takeuchi et al., 2006) Neural crest development (Barembaum and Bronner-Fraser, 2004) , ear development (M Bronner Fraser, personal communication), limb development (Harvey and Logan, 2006; KoshibaTakeuchi et al., 2006) csall3 which could alter the localization and therefore function is also intriguing. Another related question concerns the mode of action of truncated spalt proteins, such as those potentially involved in TBS. N terminal truncations of SALL1 group proteins can remove full-length spalt proteins from the nucleus; however, a fusion of such an N terminal truncation to the glucocorticoid receptor shows enhanced repressor activity upon addition of dexamethasone (Onai et al., 2004) . So it appears that these truncations can act to antagonize full-length protein function in multiple ways within the cell interfering with protein function both within and outside the nucleus. The model shown in Fig. 3 summarizes our current understanding of spalt protein function. In the nucleus, spalt proteins may act in combination to activate or repress expression of target genes while 'TBS like' truncations can interfere with this activity (Fig. 3A) . 'TBS like' truncations may also abrogate the function of full-length spalt proteins by relocalizing them into the cytoplasm (Fig. 3B ). Sall3 proteins may also act as negative regulators of other spalts by removing them from the nucleus although this may depend on the phosphorylation state of the sall3 protein (Fig. 3C) .
Conclusions
This review illustrates that the spalt family of proteins are involved in many fundamental processes during development. Their roles and mechanisms of action are beginning to be elucidated by developmental biologists and clinical scientists; however, many exciting questions remain unanswered. Some of these aspects of spalt protein biology are summarized in Table 2 and we can look forward to learning more about the diverse developmental, cellular and molecular roles of this protein family.
